Significant attenuation of the hyperoxia-induced lung inflammation and injuries with MSC transplantation in WT mice as well as in FPR1-/- mice regardless of MSCs transplantation suggests that FPR1 could be a potential novel therapeutic target in BPD. This evidence concerns the gene FPR1 and bronchopulmonary dysplasia.